United States · FDA National Drug Code directory
Rayaldee
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70301-1002_7a2aae40-1f27-460f-bc3b-7227ce031d4e
- Product NDC
- 70301-1002
- Form
- CAPSULE, EXTENDED RELEASE
- Composition / generic term
- calcifediol
- Labeler
- OPKO Pharmaceuticals LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20240311
- Source listing expiry
- 20271231
Source-listed ingredients
- CALCIFEDIOL — 30 ug/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70301-1002-1) · 70301-1002-1
- 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70301-1002-2) · 70301-1002-2
- 7 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70301-1002-3) · 70301-1002-3
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →